Complete new facility construction and related developments
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 28 Feb 2023
- Due
- 31 Dec 2023
- Delivered
- 25 Oct 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The company remains on-track to substantially complete both new facility construction and related developments and capital expenditure targets in 2023.”
What we found
Evidence strength B What the grades mean
Myriad Genetics completed new facility construction in 2023, opening Campus West facility in Salt Lake City on October 25, 2023, within the stated deadline.
-
B Myriad Genetics Q3 2023 Earnings
“Significant progress on upgrading lab and IT infrastructure and capabilities; successful opening of South San Francisco and Salt Lake City facilities”
-
B Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
“Capital expenditures and capitalization of internal use software costs were $14 million in the fourth quarter 2023” ✓ confirmed on the page
-
D Myriad Genetics Inaugurates West Campus
“On Wednesday, October 25th, 2023, Myriad Genetics West Campus officially opened with the ribbon cut by President and CEO, Paul J. Diaz, and Joe Romero, the Vice President of Real Estate & Facilities.” ✓ confirmed on the page
Checked 4 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Construction
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- new facility construction
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Myriad Genetics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-MYGN-003923 · Corrections policy